Those drugs have different molecular structures than orforglipron, Wharton says, which could explain why orforglipron didnt cause the same trouble
Beyond supply issues, cost and coverage remain hurdles
Though several molecules, such as mazdutide, a GLP/glucagon dual agonist, are being studied in various phases, the first agent targeting incretins other than just GLP-1 was approved in 2022 tirzepatide [41]
Women should stop taking Ozempic and Wegovy at least two months before they plan to get pregnant to clear the medication from their body, according to the prescribing information
September 19, 2025 10:48 View More Beyond the Hype The Truth About GLP-1s, Weight Loss & Healing with Melissa Afflerbach In this special in-person episode of the Modern Thyroid and Wellness podcast, host McCall McPherson is joined by Melissa Afflerbach, Program Director at Modern Weight Loss, for a candid and empowering discussion about GLP-1 medications like semaglutide and their evolving role in weight loss and metabolic health
Molecular mechanisms underlying the impact of GLP-1RAs on cancer risk The regulation of cancer risk by GLP-1RAs involves several biological mechanisms, primarily encompassing metabolic regulation, direct anti-tumor effects, immune modulation, and epigenetic alterations
